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UNIT A4.3Human Immunodeficiency Virus (HIV)
Magnetic resonance imaging (MRI) for the evaluation of patients infected with human
immunodeficiency virus (HIV), as with most other forms of intracranial inflammatory or
infectious diseases, is a powerful though largely nonspecific diagnostic tool. For imaging
of these complex patients with the varied and numerous pathologies they may harbor, the
Basic Protocol presented in UNIT A4.1 is utilized to include gadolinium-enhanced se-
quences. Several optional imaging sequences, to include magnetic resonance diffusion
(dMRI), magnetic resonance perfusion (pMRI), and magnetic resonance spectroscopy
(MRS) are outlined, which can be employed should patient tolerance allow and if specific
clinical situations exist to be further clarified. The parameters given here are derived from
experience at 1.5 T and may need to be altered slightly depending on the field strength
available and the specific equipment manufacturer.
BASIC
PROTOCOL
IMAGING OF HIV
This protocol presents the authors routine MR head examination for patients with
intracranial inflammatory disease, with gadolinium contrast agent sequences. The total
number of sequences presented is seven (scout, T1-weighted sagittal and transverse,
fluid-attenuated inversion recover (FLAIR) and fast spin-echo (FSE) T2-weighted trans-
verse, and post-contrast T1-weighted transverse and coronal). This examination may be
shortened considerably by limiting the use of two planes for post-contrast imaging to a
single transverse plane for exams with a lower clinical suspicion for disease, or if review
of the images obtained through the transverse gadolinium-enhanced images proves
unremarkable. The sequences described herein are based on the authors’ experience with
a Marconi Medical Systems 1.5-T scanner, but are expected to be equally applicable to
machines from other manufacturers. The authors utilize the same basic scanning protocol
to image HIV patients as that for other cerebral inflammatory conditions (UNIT A4.1), which
follows below.
Table A4.3.1 lists the hardware necessary to perform the examination, along with
appropriate parameters.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as a crash cart or oxygen. Also ensure only magnetic field compatible oxygen
tanks are utilized if wall-source oxygen is unavailable.
Materials
Extravascular contrast agent (e.g., 0.1 mmol/kg patient body weight of gadolinium
chelate from Mangevist, Omniscan, or Prohance)
Normal saline (0.9% NaCl) sterile
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Table A4.3.1 Equipment Parameters for Contrast-Enhanced Head
Imaging Sequences
Coil type Head
Gradient coil strength 25 mT/m (or whatever the
system permits)
Gating (cardiac, respiratory,
peripheral)
No
Respirator or oxygen If required by patient
Motion cushions Recommended
Contrast agents Yes
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Set up patient and equipment
1. Interview (screen) the patient to ensure that he/she has no contraindication for MR
scanning such as cardiac pacemaker or other implants containing ferromagnetic
materials. Also be sure to find out if the patient has any health conditions that may
require the presence of special emergency equipment during the scanning procedure,
or that necessitate other special precautions.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient remove any mascara or other metal-containing makeup to avoid local
tissue heating and image artifacts.
5. Inform the patient about what will occur during the procedure, what he/she will
experience while in the magnet, and how to behave, to include the following:
a. If earphones/headphones are used to protect the ears from loud sounds produced
by the scanner, the patient will be asked to wear these, but will be able to
communicate with the technologist at any/all times during the procedure.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this equipment works).
c. For optimum results the patient should not talk, and should avoid/minimize
swallowing or other movement during each scan, i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed. The patient will be informed in these instances.
d. Nevertheless, the patient may call out at any time if he/she feels it necessary.
6. Have the patient lay supine on the scanner table. Either before or directly after the
patient is positioned on the table, set up any triggering devices or other monitoring
equipment necessary.
7. Establish an intravenous (i.v.) line through which the contrast agent can be injected,
and attach this line securely to the patient so that movement into or out of the magnet
will not pull at the patient’s arm. It is preferable to insert the line prior to imaging.
This allows no intervening motion between those scans performed before and those
run after the contrast agent injection.
8. Center the patient in the head coil. Make sure that the head and neck are constrained
to prevent unnecessary motion, especially if high-resolution scans are to be run.
9. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
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10. Use the centering light to center on the nasion of the patient and place them into the
center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
11. If the patient is unable to hold still, either provide an appropriate sedative, or arrange
with anesthesiology for conscious or general anesthesia.
Alternatively, a low-field open magnet may be sought for scanning the claustrophobic
patient. There are also fast scanning techniques that may be employed for imaging of these
patients (see Chapter A5).
12. This Basic Protocol can be performed in <30 min.
Sequence 1: Rapid three-plane pilot
13. Run the three-plane pilot (Table A4.3.2) sequence to evaluate the patient positioning
in the magnet.
14. This sequence runs in <10 sec and is used to position the remainder of the sequences.
It is particularly useful to correct off-axis positioning in the coronal plane.
Sequence 2: T1-sagittal head
15. This sequence serves as a true T1-weighted sagittal study of the head. Bring the
sequence for a sagittal T1-weighted scan up onto the console and utilize the parame-
ters in Table A4.3.3.
16. Use the pilot sequence to set up the scan levels.
17. Let the patient know you are ready, and begin the scan.
Table A4.3.2 Primary Clinical Imaging Parameters for Sequence 1: Rapid
Three-Plane Pilot
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal, transverse, and coronal
Central slice or volume center Midline head
Echo time (TE) 3.7 msec
Repeat time (TR) 16 msec
Flip angle (FA) 20°
Fields of view (FOVx, FOVy) 300 mm, 300 mm
Resolution (∆x, ∆y) 2.34 mm, 2.34 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 3
Slice gap NA
Number of acquisitions (Nacq) 1
Read direction Left–right
Slice locations At isocenter, 3 orthogonal planes
Saturation pulses None
RAMa 2X
Scan time 6 sec
aZero padded from 128 by 128 points to 256 by 256 points.
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Sequence 3: T1-transverse head
18. Bring the sequence for a transverse T1-weighted scan up onto the console. Set the
imaging parameters as shown in Table A4.3.4.
19. Use the pilot sequence to set up the scan levels.
20. Let the patient know you are ready, and begin the scan.
Table A4.3.3 Primary Clinical Imaging Parameters for Sequence 2: T1-Sagittal
Head
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Midline head
Echo time (TE) 12 msec
Repeat time (TR) 300 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 1.25 mm, 0.94 mm
Number of data points collected (Nx, Ny) 192, 256
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 4 mm
Number of slices 15
Slice gap 1 mm
Number of acquisitions (Nacq) 1
Read direction Superior–inferior
Slice locations Cover brain parenchyma
Saturation pulses None
Scan time 1 min, 55 sec
Table A4.3.4 Primary Clinical Imaging Parameters for Sequence 3:
T1-Transverse Head
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse (planum sphenoidale
line)
Central slice or volume center Mid-cranium
Echo time (TE) 12.1 msec
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 180 mm
Resolution (∆x, ∆y) 0.94 mm, 0.94 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Slice locations Foramen magnum to vertex
Saturation pulses None
Scan time 2 min, 36 sec
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Sequence 4: FLAIR transverse head
21. Bring the sequence for a transverse FLAIR scan up onto the console. Set the imaging
parameters as shown in Table A4.3.5.
22. Use the pilot sequence to set up the scan levels and a caudal saturation pulse.
23. Let the patient know you are ready, and begin the scan.
Sequence 5: FSE transverse head
24. Bring the sequence for a transverse FSE scan up onto the console. Set the imaging
parameters as shown in Table A4.3.6.
25. Use the pilot sequence to set up the scan levels.
26. Let the patient know you are ready, and begin the scan.
Sequence 6: T1-transverse post-gadolinium head
27. Bring the sequence for a transverse T1-weighted scan up onto the console. Set the
imaging parameters as shown in Table A4.3.7.
28. Use the pilot sequence to set up the scan levels.
29. Leaving the patient in the magnet, inject the contrast agent. This may be by either
hand or by a mechanical injector. Observe the injection to insure there is no
extravasation of the contrast agent. Flush the line with 10 ml of sterile normal saline.
The scan may begin as soon as the injection is completed.
Alternatively, the scanning table may be advanced out of the magnet for the injection, but
the patient must remain in place.
A dose of 0.1 mmol/kg of contrast agent is usually given.
This is essentially the same sequence as the pre-gadolinium scan, but can be performed
with the addition of a flow compensation (FC) pulse to better delineate the cerebral vessels,
and a magnetization transfer (MT) pulse to optimize enhancing lesion detection.
Table A4.3.5 Primary Clinical Imaging Parameters for Sequence 4: FLAIR
Transverse Head
Patient position Supine
Scan type FLAIR-FSE
Imaging plane (orientation) Transverse (parallel to AC-PC line)
Central slice or volume center Mid-cranium
Echo time (TE) 125 msec (effective)
Echo train length (ETL) Fixed (generally 12)
Repeat time (TR) 6000 msec
Inversion time (TI) 1900 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 240 mm, 197 mm
Resolution (∆x, ∆y) 0.94 mm, 0.87 mm
Number of data points collected (Nx, Ny) 256, 204
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Slice locations Foramen magnum to vertex
Saturation pulses Caudal to saturate arterial flow
Scan time 2 min, 48 sec
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Table A4.3.6 Primary Clinical Imaging Parameters for Sequence 5: FSE
Transverse Head
Patient position Supine
Scan type Fast spin echo (FSE)
Imaging plane (orientation) Transverse (planum sphenoidale
line)
Central slice or volume center Mid-cranium
Echo time (TE) 105 msec (effective)
Echo train length (ETL) 16
Repeat time (TR) 5616 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 180 mm
Resolution (∆x, ∆y) 0.63 mm, 0.70 mm
Number of data points collected (Nx, Ny) 384, 256
Display matrix (Dx, Dy) 384, 384
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Slice locations Foramen magnum to vertex
Saturation pulses Caudal to saturate arterial flow
Scan time 3 min, 22 sec
Table A4.3.7 Primary Clinical Imaging Parameters for Sequence 6:
T1-Transverse Post-Gadolinium Head
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse (planum sphenoidale
line)
Central slice or volume center Mid-cranium
Echo time (TE) 12.1 msec
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 180 mm
Resolution (∆x, ∆y) 0.94 mm, 0.94 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Slice locations Foramen magnum to vertex
Saturation pulses None
Scan time 2 min, 36 sec
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Sequence 7: T1-coronal post-gadolinium head
30. Bring the sequence for a T1-weighted scan up onto the console. Set the imaging
parameters as shown in Table A4.3.8.
31. Use the pilot sequence to set up the scan levels.
32. Let the patient know you are ready, and begin the scan.
Small abscesses may be much better delineated with a smaller field of view (FOV; e.g.,
FOVx = 200 mm, FOVy = 150 mm) and higher resolution thinner slice thickness (e.g., 3
mm). Please note that this modification should be performed with one acquisition, and
limited to the area of abnormality to avoid prolonged scan times.
When scanning pediatric patients (under 24 months) modify the transverse and coronal
sequences by placing the FOV at 200 mm, and the slice thickness and gap at 4 mm and 1
mm, respectively. For neonates, premature infants, and other extremely small patients an
extremity coil may be used.
This sequence may be performed with the addition of a flow compensation (FC) pulse to
better delineate the cerebral vessels, and a magnetization transfer (MT) pulse to optimize
enhancing lesion detection.
ALTERNATE
PROTOCOL
SPECIAL SITUATIONS
The three sequences that follow (gradient echo; 3-dimensional gradient echo post-gad-
olinium; magnetic resonance angiogram or venogram) are presented here for considera-
tion by the radiologist in those patients suspected of significant intracranial HIV-related
inflammatory conditions for whom the Basic Protocol has failed to elucidate a clearly
defined abnormality. These patients can suffer intracranial lesional hemorrhage, for which
the gradient echo sequence is extremely useful for demonstrating microhemorrhage. This
can produce not only the helpful diagnostic clue of a hemorrhagic lesion but may well
bring other lesions to the attention of the radiologist. This may in turn impact upon patient
Table A4.3.8 Primary Clinical Imaging Parameters for Sequence 7: T1-Coronal
Post-Gadolinium Head
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal (perpendicular to planum
sphenoidale line)
Central slice or volume center Mid-cranium
Echo time (TE) 12.1 msec
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 220 mm, 178 mm
Resolution (∆x, ∆y) 0.86 mm, 0.93 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of acquisitions (Nacq) 2
Read direction Superior–inferior
Slice locations Frontal to occipital cerebral poles
Saturation pulses None
Scan time 2 min, 36 sec
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prognosis, or guide more effective follow-up imaging. The second optional sequence
(3-dimensional gradient echo post-contrast) is usually reserved for higher resolution of
small lesions or adjacent structures that may be affected by the pathology. It can also be
an effective aid in operative planning, and may indeed serve as the base MRI sequence
for several of the commercially available image-guided surgery tools presently on the
market and utilized by many neurosurgeons. This sequence can be utilized in lieu of the
transverse and coronal post-gadolinium sequences outlined in the Basic Protocol, if
desired. It is easily manipulated in post-processing to yield a desired projection of a lesion,
or simply to give a multiplanar assessment of the brain in a given patient. Magnetic
resonance angiography or venography can aid in detection of an associated (inflamma-
tory) angiitis, most often manifest in the HIV patient as venous thrombosis. Gadolinium
administration may disclose such abnormalities more effectively, as it provides greater
signal-to-noise within the vascular tree. This improves conspicuity of subtle findings in
the larger vessels and increases visibility of the smaller vascular structures.
Set up patient and equipment
1. Use the same equipment and the same patient set-up as for the previous method (see
Basic Protocol, steps 1 to 11).
2. Run the pilot scan as sequence 1 in the Basic Protocol.
Sequence 8: Coronal gradient echo (head)
3. Bring the sequence for a gradient echo scan up onto the console. Set the imaging
parameters as shown in Table A4.3.9.
4. Use the pilot sequence to set up the scan levels.
5. Let the patient know you are ready, and begin the scan.
Sequence 9: 3-Dimensional post-gadolinium transverse gradient echo (head)
6. Repeat step 29 in the Basic Protocol.
7. This sequence is often employed when scanning patients with HIV and may do so in
lieu of the routine post-contrast 2-D transverse and coronal spin echo sequences
described in the Basic Protocol, or when surgery is contemplated. It can be used to
better delineate smaller lesions and can be reformatted into any desired plane as it is
a volume-acquired sequence performed with high resolution parameters as described
in Table A.4.3.10.
8. This scan generates 120 images as a whole brain study, but higher resolution image
sets with 32 or 64 images, with a resolution as low as 1 mm can be produced, but
may be restrictive in area of coverage.
9. Planar reformations of the 3-D data set can be performed on- or off-line using the
reformation software. One can coordinate with the neurosurgeon to obtain the most
useful projections, which can then be saved and/or filmed.
10. Note that the cerebral vasculature is quite bright on this sequence as this 3-D gradient
echo sequence is the base-sequence for time-of-flight (TOF) magnetic resonance
angiography (MRA).
Sequence 10: Magnetic resonance angiography (MRA) and venography (MRV)
11. These sequences may be employed when the specific history provided for a patient
suggests possible arterial or venous pathology, or if review of the spin echo images
indicates this possibility. MRV is routinely employed when evaluating patients with
suspected meningitis, but will usually reserve the use of MRA to those patients
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Table A4.3.10 Primary Clinical Imaging Parameters for Sequence 9: 3-D
Post-Gadolinium Transverse Gradient Echo (Head)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Transverse (option sagittal, or
coronal)
Central slice or volume center Mid-cranium for whole brain, or
area of abnormality
Echo time (TE) 5 msec
Repeat time (TR) 11.2 msec (or minimum)
Flip angle (FA) 35°
Fields of view (FOVx, FOVy) 240 mm, 187 mm
Resolution (∆x, ∆y) 0.94 mm, 0.97 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 1.2 mm
Number of slices 120
Slice gap 0 mm
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior, if imaging
plane is transverse
Slice locations Whole brain
No phase wrap (NPW)a Yes
Saturation pulses NA
Scan time 4 min, 19 sec
aPhase oversampling or anti-alrasing.
Table A4.3.9 Primary Clinical Imaging Parameters for Sequence 8: Coronal
Gradient Echo (Head)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Coronal
Central slice or volume center Mid-cranium
Echo time (TE) 24.6 msec
Repeat time (TR) 719 msec
Flip angle (FA) 25°
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (∆x, ∆y) 0.86 mm, 1.15 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 21
Slice gap 1 mm
Number of acquisitions (Nacq) 2
Read direction Superior–inferior
Slice locations Frontal to occipital cerebral poles
Saturation pulses None
Scan time 4 min, 36 sec
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demonstrating concerning arterial findings on spin echo images, or with suspicious
hemorrhage noted. The reader is referred to the scanning parameters outlined for
these sequences in Chapter A1 of this series.
COMMENTARY
Background Information
Human immunodeficiency virus (HIV) is
the virus responsible for the AIDS epidemic. In
the United States, an estimated 650,000 to
900,000 people are infected with HIV, and
>200,000 of these individuals are unaware of
their infection (Fauci, 1999; Wong and Quint,
1999). There are 40,000 new infections per year
with the infection rate in heterosexuals, and
especially women, accelerating greatly in the
1990s. Worldwide in 1998 there were >33 mil-
lion people worldwide with HIV infection and
AIDS was listed as the fourth leading cause of
death, with an estimated number of 2.3 million.
However, the age-adjusted death rate from
AIDS in the United States declined 48% from
1996 to 1997. This improvement in the death
rate is multifactorial in origin, but largely the
result of new treatment advances, in particular
the development of highly active antiretroviral
therapy (HAART). These developments under-
score the need for early and accurate diagnosis
and follow-up of these challenging patients.
There remain subsets of pathologies in the
AIDS population that are refractory to treat-
ment at this time. Chief among these is progres-
sive multifocal leukoencephalopathy (PML).
This fulminant opportunistic central nervous
system (CNS) infection occurs in 4% of AIDS
patients and is caused by the Jakob-Creutzfeldt
(JC) papovavirus (JCV). It carries a mean sur-
vival of 2.5 to 4 months from the time of
diagnosis. Whereas brain biopsy was pre-
viously the mainstay for the diagnosis of PML,
recent advances in cerebrospinal fluid (CSF)
analysis (>92% specific for JCV) when coupled
with typical MR changes of the disease and a
clinical presentation consistent with PML, have
produced an accepted and much less invasive
diagnostic regimen (Donovan-Post et al.,
1999).
Approximately 40% to 90% of patients with
AIDS will develop CNS manifestations during
the course of the illness (Walot et al., 1996).
The most common of these opportunistic infec-
tions are caused by toxoplasma, cytomega-
lovirus (CMV), cryptococcus, and the JCV
causing PML. Less commonly observed agents
include herpes simplex virus (HSV), varicella-
zoster, histoplasmosis and tuberculosis. The
imaging diagnosis of these many varied pa-
thologies found in HIV patients is most devel-
oped presently with MRI, but may require the
addition of other imaging techniques such as
computed tomography (CT), single-photon
emission computed tomography (SPECT), and
positron emission tomography (PET). A simple
method to add a degree of specificity to the
diagnostic workup is to search for primary
infection sources in the patient, such as the
lungs for many of the infectious agents. Differ-
ent pathologies may occur synchronously or
sequentially, confusing attempts at simplified
diagnosis in these patients. The most common
example of this being the problematic differen-
tiation of the lesions of toxoplasmosis from
lymphoma. Clinical presentation depends more
on anatomic location within the CNS than on
lesion etiology. A categorization scheme is dis-
cussed below (see Anticipated Results), con-
sisting of four lesion classes, (1) focal lesions
with mass effect; (2) focal lesions without sig-
nificant mass effect; (3) diffuse global CNS
abnormalities; and (4) ventriculitis, meningitis,
and infarcts (Walot et al., 1996).
Critical Parameters and
Troubleshooting
Please see the discussions presented in UNITS
A4.1 and A4.2 for useful remarks in optimizing
the Basic Protocol. Some additional discussion
related to the imaging of HIV infected patients
is warranted. Considering the utility and bene-
fits of the contrast-enhanced 3-D gradient echo
sequence if used as a whole brain sequence, it
can either supplement or replace the post-con-
trast transverse and coronal spin echo se-
quences. It affords superior spatial resolution
and some time savings, but at some mild loss
of signal-to-noise contrast. The sequence is
routinely performed as a problem-solver in that
the high resolution images (especially when
limited to area of interest with thinner slice
thickness) can give the exact location of subtle
lesions (i.e., in the subarachnoid space of a
cerebral sulcus or within adjacent cerebral cor-
tex). This determination is readily aided by the
ability to reformat the sequence into any desired
plane.
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There is a distinct though rare association of
HIV and AIDS with CNS vasculopathy, par-
ticularly in the pediatric AIDS population
(Shah et al., 1996). The prudent MR imager
will remain vigilant for this occurrence and
employ either 3-D gradient echo or directed
MRA studies to further evaluate the patient.
The findings can be subtle when early in their
development, but can rapidly advance to a
markedly abnormal vessel contour, rupture and
associated hemorrhage, or thrombosis and in-
farction. Alternatively, when infarction or hem-
orrhage are noted, clues to the presence, loca-
tion, and severity of vasculopathy should be
assessed. The authors have found it occasion-
ally useful to perform MRA/MRV after the
administration of gadolinium in order to obtain
superior signal-to-noise from the vessels. This
can be especially important when examining
the small and hyperdynamic vessels found in
the pediatric age group. Also, contrast admini-
stration may allow for the evaluation of more
distal arterial vessels of the brain (i.e., M2
segment of the middle cerebral artery and be-
yond) that would not otherwise afford sufficient
signal for scrutiny. Such is the case in coopera-
tive patients, but in uncooperative patients,
there is often a delay obtaining motion sensitive
studies such as MRA until adequate sedation
can be obtained. Though specifically in diffi-
cult patients, gadolinium enhanced MRA may
give sufficient signal in the larger arterial struc-
tures of the circle-of-Willis for sufficient diag-
nostic confidence.
The occurrence of the AIDS dementia com-
plex (ADC) in AIDS patients, as well as altered
sensorium related to more focal pathologies in
this population make fast scanning technique
familiarization important. For a more detailed
discussion of fast-scan techniques, please refer
to Chapter A5 of this series. Additional time
savings for imaging these patients can be found
by limiting pre-contrast and post-contrast T1-
weighted sequences to one plane each, per-
forming only one acquisition (Nacq) on each
sequence, or alternatively by utilizing FSE T1-
weighted sequences rather than routine T1-
weighted sequences. These maneuvers will
limit all SNR and sensitivity for detection of
abnormal contrast enhancement and subtle le-
sions but will afford faster exam times. The
marked speed of acquisition for dMRI make it
a desirable sequence in these patients, as well.
It can provide both T2-weighted and diffusion
data.
For the always difficult differentiation of
toxoplasmosis from lymphoma, several helpful
clues should be sought. The presence of micro-
hemorrhage within lesions is a good indicator
of toxoplasmosis. This determination is aided
by the judicious use of the gradient echo se-
quence (sequence 8), which can readily display
hemorrhagic blood products that might other-
wise be extremely subtle, or even invisible on
routine spin echo sequences (Figure A4.1.3).
MRS and pMRI can also be helpful, if the
reader’s scanner is equipped for these studies.
Finally, the utility of MR for follow-up im-
aging cannot be overstressed for HIV infected
patients. The pathologies found in this group
demand repeat imaging, often over extended
periods of months and years and after multiple
associated interventions such as surgery, bi-
opsy, and of course, anti-infectious therapies.
It is important to attempt standardization of
protocols from one imaging session to the next
to avoid the “apples-to-oranges” effect that can
handicap the radiologist’s ability to assess for
lesion change over time.
Imaging of HIV by magnetic resonance
diffusion, perfusion, and spectroscopy
The Basic Protocol outlined above is quite
sufficient in most instances and represents the
standard for imaging of the patient with HIV.
However, in certain clinical instances there may
remain confusion as to the diagnosis, or in order
to gain a higher degree of specificity in labeling
a lesion, further imaging can be performed
utilizing dMRI, pMRI, or MRS. Recent litera-
ture (Chang et al., 1995; Ernst et al., 1998) has
indicated diagnostic benefit in some clinical
and imaging differential situations with these
functions, with the greatest added utility in HIV
patients presently residing with MRS. Please
refer to the scan parameters and set-up outlined
in detail in UNIT A4.1 of this chapter for perform-
ance of these sequences.
pMRI of the brain. This sequence is per-
formed to assess vascular perfusion of the brain
and pathologic foci. pMRI can help in differ-
entiating abscess from necrotic neoplasm. It is
a rapid acquisition with moderate spatial reso-
lution which can yield information on the entire
brain and multiple lesions, even in agitated
patients.
Echo-planar imaging (EPI) dMRI of the
brain. This sequence is performed to assess
water motion (proton diffusion) within the
brain parenchyma. Diffusion imaging may help
in the differential diagnosis of cerebral abscess
vs. necrotic neoplasm. It is a rapid acquisition
(scan time 28 sec) with moderate spatial reso-
lution that can yield information on the entire
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brain and multiple lesions, even in agitated
patients.
MRS of the brain. This sequence will pro-
vide information as to the specific molecular
substrate(s) within an area of interest, which
may indicate the presence of abnormal tissue
or metabolic processes. MRS can be used in the
diagnosis and follow-up of cerebral abscess,
encephalitis, regions of demyelination, or tu-
mors. The sequence acquisition time is ∼10 min
per TE performed, making useful results diffi-
cult to obtain in agitated patients. A tracing of
the magnetic spectra of the molecular contents
of the voxel is produced for analysis.
Anticipated Results
Focal brain lesions with mass effect are
found in 15% to 20% of AIDS patients and, as
a class, represent the most important patholo-
gies for accurate identification as generally
effective therapies are available (Walot et al.,
1996). As AIDS is fundamentally an immune
system compromising illness, there can be dis-
tinct and confusing differences in the appear-
ance of pathologic entities in the AIDS patient
when compared to similar pathologies in the
normal population. Specifically, the inflamma-
tory response can be weak in the immunocom-
promised patient, which may lead to a decrease
in reactive edema found around inflammatory
or neoplastic lesions, and poor contrast en-
hancement. However, tumors that would nor-
mally enhance will usually continue to do so,
as neoplasia involves the formation of abnor-
mal tumor vessels that leak contrast agent and
are not subject to an inflammatory factor.
Toxoplasma gondii is the protozoan responsi-
ble for the most common opportunistic CNS
infection in AIDS patients (13% to 33% of
AIDS patients with CNS disease). Encephalitis
and abscess can result from reactivation of the
organism in the immunocompromised host.
The primary means of differentiating toxoplas-
mosis from lymphoma in the CNS remains a
satisfactory response to antitoxoplasma thera-
pies, with noticeable lesion regression seen on
imaging studies by 2 weeks. Toxoplasmosis
tends to present with multiple lesions and the
presence of small lesional hemorrhages is sup-
portive of the diagnosis (Taveras and Pile-
Spellman, 1996). However, a solitary lesion at
presentation is not uncommon (∼30%). Pri-
mary lymphoma is the most common neoplasm
in AIDS patients, and is almost always of the
high-grade B-cell type. It is also most often
multifocal at presentation (80% to 100%) and
hemorrhage in these lesions is distinctly un-
usual. Though typically solid tumors, lym-
phoma may display necrosis (an unusual find-
ing in non-AIDS patients) and ring enhance-
ment, especially when larger. The ring enhance-
ment is often less distinct and thicker (>3 mm)
than that seen with toxoplasmosis. Lymphoma
is isointense to brain on both T1-weighted and
T2-weighted MR images, with occasional hy-
pointensity seen on T2-weighted images due to
the high cellularity of the process and the high
nuclear/cytoplasmic ratio. It occurs centrally in
the basal ganglia, corpus callosum, and
periventricular white matter. Subependymal
spread and ventricular encasement are also
common.
Despite these appearances and their seeming
differences, the imaging characteristics of
toxoplasmosis and lymphoma overlap to a sig-
nificant degree, and in fact have been reported
to occur together in the same patient (Walot et
al., 1996; Wong and Quint, 1999). With therapy
all lesions must thus be closely monitored.
pMRI and MRS have been used to further
differentiate these pathologies (see discussion
in UNIT A4.1; Chang et al., 1995; Ernst et al.,
1998). Toxoplasmosis tends to demonstrate
marked elevation of the lactate and lipid peaks
on MRS and normal metabolite depletion,
while lymphoma produces an elevated choline
peak with moderate elevation of the lactate and
lipid peaks. These spectra are thought secon-
dary to the more infiltrating and solid nature of
the neoplasm compared to the more typically
necrotic and abscessed infectious lesion.
Cryptococcosis, an infection from the yeast
Cryptococcus neoformans, occurs in 5% of
AIDS patients and can be varied in presentation
and structural involvement of the CNS (Harris
and Enterline, 1997). However, meningitis is
certainly most common at presentation. Inflam-
matory response by the CNS to invasion by
cryptococcus is muted as the organism elabo-
rates a mucinous capsule. Thus, meningeal en-
hancement is rarely noted. However, the organ-
ism proliferates in the subarachnoid space and
characteristically settles in the perivascular
spaces of Virchow-Robin, where it fills these
spaces with organisms and mucoid exudate
leading to lesions termed “gelatinous pseudo-
cysts” (Figure A4.3.1). These pseudocysts have
signal characteristics similar to CSF, but may
be detected on FLAIR or proton-density images
with abnormal high T2 signal in dilated and
unusually numerous Virchow-Robin spaces,
which are seen mostly at the base of the brain
and in the brainstem (predominantly the mid-
brain).
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AIDS patients do not have a particular sus-
ceptibility to pyogenic abscess formation or
tuberculosis, but these infections can still be
seen in the i.v. drug abusing subset of the AIDS
population (Walot et al., 1996). Neurotubercu-
losis presentations are varied with cerebritis, or
focal parenchymal or meningeal lesions seen
typically with prominent and diffuse enhance-
ment, though true abscess formation may occur.
The simultaneous occurrence of basilar menin-
gitis and associated hydrocephalus is a strong
indicator of tuberculous infection, or another
granulomatous process such as fungal infection
by coccidioidomycosis.
The second broad category of CNS abnor-
malities in AIDS patients is focal lesions with-
out significant mass effect. These processes
generally involve only white matter without
producing significant edema, and usually with-
out associated enhancement after administra-
tion of gadolinium chelates. The lesions are of
low signal on T1-weighted MR images, and
demonstrate high T2 signal intensity. This ap-
pearance is nonspecific, being produced by
lesions of multiple sclerosis, post-infectious
demyelinating conditions such as acute dis-
seminated encephalomyelitis (ADEM) and is-
chemic processes in the elderly population. Of
paramount concern among these is PML that
represents a reactivation of the dormant JCV
found in 80% of the normal adult population.
The virus infects and destroys oligodendro-
cytes causing the demyelination. The lesions
are usually multiple, confluent and bilateral
(though asymmetric) at presentation, and found
in the white matter, primarily in subcortical,
periventricular, and centrum semiovale loca-
tions. The process rarely enhances (2%) and
may have mild associated cortical atrophy
(Donovan-Post et al., 1999). The main differ-
ential consideration with PML is that of pri-
mary HIV or CMV cerebritis. These conditions
characteristically have advanced associated at-
rophy of the cerebral structures on presentation.
Additionally PML, as the name implies, can
progress. This progression may be startlingly
rapid with serial MR studies depicting marked
progression in many patients within 9 weeks.
Figure A4.3.1 This T2-weighted (TR = 2500 msec, TE = 80
msec, Nacq = 0.75) transverse image at the basal ganglia level
demonstrates a cluster of rounded lesions (arrowheads) in the
left globus pallidus and posterior limb of the internal capsule with
mild increased T2 signal in adjacent brain. Minimal mass effect
is present. The CSF disclosed cryptococcal infection, and “ge-
latinous pseudocysts” within the perivascular spaces of Virchow-
Robin were diagnosed.
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MRS has been described for AIDS patients and
PML (Chang et al., 1995) and suggests a sig-
nificant contribution to specificity in distin-
guishing amongst the many differential diag-
nostic possibilities when coupled with the re-
sults of spin-echo examination.
In considering the third broad category of
CNS lesions found in AIDS patients, diffuse
global CNS abnormalities, the most common
presentation is that of iso-intense to hypo-in-
tense T1 signal relative to brain, with subtle and
diffuse abnormal increased T2 signal located
predominantly in the cerebral white matter in a
symmetric manner. This is seen with associated
diffuse and often marked cerebral atrophy
(which in itself may be the only finding). The
most common cause of this constellation of
findings is direct CNS infection by HIV, a
neurotropic virus. No enhancement is present
in the regions of abnormal signal and MRS
shows neuronal loss with a decrease of the
N-acetylaspartate (NAA) peak (a neuronal
marker).  Clinically, an associated
encephalopathy may be noted (ADC). Autopsy
studies have shown a high prevalence of a
concurrent CMV infection, though this patho-
gen is believed to invade the brain later in the
course of the illness.
Finally, ventriculitis, meningitis, and in-
farcts comprise the fourth category of CNS
abnormality. CMV may cause an aggressive
ventriculoencephalitis, the diagnostic clue to
which can often be found with CMV infection
elsewhere in the body (most notably CMV
retinitis). The ventricles are enlarged, generally
from associated atrophy, with increased T2 sig-
nal seen in subependymal location along with
poorly defined periventricular enhancement
(Figure A4.3.2). This viral agent also has a
tendency to spread to the meninges and adja-
cent cranial nerves. CNS vasculopathy, which
can lead to ischemic or hemorrhagic infarction,
will rarely affect the larger arterial structures
(circle-of-Willis) at the base of the brain and
can lead to fusiform aneurysm formation, as
well as sclerosis and thrombosis (Figure
A B
Figure A4.3.2 A coronal (A) FSE T2 image through the third ventricle (TR = 5600 msec, TE = 105 msec,
Nacq = 2; echo train length = 8) discloses abnormal increased T2 signal in the subependymal and
immediate periventricular white matter (arrowheads). The corresponding post-contrast T1-weighted (B)
coronal image (TR = 500 msec, TE = 12 msec, Nacq = 1) shows linear ependymal enhancement
(arrowheads) compatible with presumed CMV ventriculitis and ependymitis. This diagnosis was supported
in this 33-year-old female with AIDS by a concurrent CMV retinitis. The authors utilized the additional
coronal FSE sequence (A) in this patient primarily as a means of evaluating the optic pathways in this
patient with CMV retinitis.
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A4.3.3). This may be the result of spread to the
vessel wall (presumably the adventitia primar-
ily) via meningeal infection and inflammation,
or possibly a direct vascular infection via the
hematogenous route. This vasculopathy has a
particular incidence in the pediatric AIDS
population and is a late manifestation of the
disease (Shah et al., 1996). It is rare to see
vasculopathy without associated abnormalities
present on spin echo images of the brain (Pom-
per et al., 1999).
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Presents a directed and concise summary of the
myriad imaging appearances encountered in this
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